logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Stefania Morganti

Harvard Medical School
H指数:24
被引数:2,653

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort

与转移性乳腺癌一线抗HER2为基础治疗中表现出非凡疗效相关的临床特征：来自ESME国家队列的真实世界数据

Breast
IF7.9
2026-10-130
OA
Thomas Grinda; Matthieu Carton; Stefania Morganti; Audrey Mailliez; Christelle Levy; Thierry Petit; Thomas Bachelot; Monica Arnedos; Véronique Diéras; Vincent Massard; Florence Dalenc; Isabelle Desmoulins; Jean-Yves Pierga; Anthony Gonçalves; Caroline Bailleux; Jean-Sebastien Frenel; Lise Bosquet; Heather A. Parsons; William Jacot; Nancy U. Lin
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort

胚系BRCA1/2携带者两组匹配队列的研究结果与治疗模式

JNCI Cancer Spectrum
IF4.1
2026-05-250
OA
Stefania Morganti, MD; Se E Kim, MB; Qingchun Jin, MPH; Jaeyoon Cha, BA; Jacqueline E Zeigler, BS; Alexandra B Newman, MD; Gregory J Kirkner, MPH; Craig Snow, MHA; Yue Zheng, MS; Julie Vincuilla, BS; Tonia Parker, BS; Ryan M Buehler, BA; Brittany L Bychkovsky, MD, MSc; Kate E Dibble, PhD; Tal Sella, MD; Kathryn J Ruddy, MD, MPH; Shoshana M Rosenberg, ScD, MPH; Laura C Collins, MD; Jeffrey Peppercorn, MD, MPH; Lidia Schapira, MD; Virginia F Borges, MD; Yaileen D Guzman-Arocho, MD; Steven E Come, MD; Ellen Warner, MD, MSc; Philip D Poorvu, MD; Matteo Lambertini, MD, PhD; Giuseppe Curigliano, MD, PhD; Melissa E Hughes, MSc; Elizabeth A Mittendorf, MD, PhD, MHCM; Tari A King, MD; Nancy U Lin, MD; Judy E Garber, MD, MPH; Nabihah Tayob, PhD; Sara M Tolaney, MD, MPH; Ann H Partridge, MD, MPH; Filipa Lynce, MD; null
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer

定量HER2组织与血浆分析可预测曲妥珠单抗德鲁克替康对乳腺癌的活性

npj Precision Oncology
IF8
2026-03-130
OAAI
Paolo Tarantino; Se-Eun Kim; Melissa E. Hughes; Ross J. Kusmick; Kalie Smith; Fara Brasó-Maristany; Nay Nwe Nyein Chan; Laia Paré Brunet; Laura Alder; Diana Garcia-Cortes; Jorge Gomez Tejeda Zanudo; Alyssa M. Pereslete; Laura Noteware; Heather Moore; Amanda E. D. Van Swearingen; Tianyu Li; Hersh Gupta; Olivia D’Amico; Alba Martini; Stefania Morganti; Jennifer Spindel; Charmaine Cook; Christine McLaughlin; Kathrin Dvir; Ana C. Garrido-Castro; Sarah Sammons; Janet Files; Kerry Sendrick; Simone Buck; Deborah Dillon; Rinath Jeselsohn; Yvonne Y. Li; Andrew D. Cherniack; Patricia LoRusso; Maryam Lustberg; Rosario Vega- León; Francisco Pardo; Justin Davis; Claudius Mueller; Brian Corgiat; Giuseppe Curigliano; Carey K. Anders; Emanuel F. Petricoin; David L. Rimm; Aleix Prat; Nabihah Tayob; Nancy U. Lin; Sara M. Tolaney
Corrigendum to: “Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis” [Eur J Cancer 145 (2021) 197–209]

勘误： “Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis” [Eur J Cancer 145 (2021) 197–209]

European Journal of Cancer
IF7.1
2025-11-290
PRE
Angela Esposito; Antonio Marra; Vincenzo Bagnardi; Samuele Frassoni; Stefania Morganti; Giulia Viale; Paola Zagami; Gianluca M. Varano; Giorgio Buccimazza; Franco Orsi; Konstantinos Venetis; Luca Mazzarella; Giuseppe Viale; Nicola Fusco; Carmen Criscitiello; Giuseppe Curigliano
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer

曲妥珠单抗德鲁替康后转移性乳腺癌患者的后续治疗方案结果

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
2025-09-012
PRE
Tarantino, Paolo; Lee, Do; Foldi, Julia; Soulos, Pamela R.; Gross, Cary P.; O'Meara, Tess; Grinda, Thomas; Morganti, Stefania; Waks, Adrienne G.; Winer, Eric P.; Lin, Nancy U.; Krop, Ian E.; Tolaney, Sara M.; Sammons, Sarah; Lustberg, Maryam
A Randomized Phase 2 Study of Neratinib With or Without Fulvestrant for Patients With HER2-Positive, Estrogen Receptor-Positive Metastatic Breast Cancer

一项关于奈拉替尼联合或不联合氟维司群治疗HER2阳性、雌激素受体阳性转移性乳腺癌的随机II期研究

Clinical Breast Cancer
IF2.5
2025-05-160
PRE
Stefania Morganti; Xiangying Chu; Tarah J. Ballinger; Nisha Unni; Sarah Sinclair; Robert Wesolowski; Alyssa M. Pereslete; Paulina Lange; Nabihah Tayob; Nancy U. Lin; Jose P. Leone; Ian E. Krop; Sara M. Tolaney; Heather A. Parsons
ASO Visual Abstract: Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy Rates

ASO视觉摘要：美国乳腺外科医师学会指南对遗传检测和对侧预防性乳房切除术率的影响

ANNALS OF SURGICAL ONCOLOGY
IF3.5
2025-05-120
PRE
Weiss, Anna; Rosito, Maria Sol; Braun, Danielle; Barton, Brenna; Mcgrath, Monica; Stokes, Sam; Laws, Alison; Warren, Laura; Morganti, Stefania; Lynce, Filipa; Bychkovsky, Brittany; Rana, Huma Q.; Davis, Dillon; Stopfer, Jill; Garber, Judy E.; King, Tari A.
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer

CDK4/6抑制剂治疗激素受体阳性、ERBB2阴性转移性乳腺癌的生存情况

JAMA NETWORK OPEN
IF9.7
2025-02-211
OA
Berton Giachetti, Pier Paolo Maria; Morganti, Stefania; Gandini, Sara; Giudici, Fabiola; Marra, Antonio; Zattarin, Emma; Corti, Chiara; Boldrini, Laura; Verrazzo, Annarita; Sposetti, Caterina; Razeti, Maria Grazia; Carnevale Schianca, Ambra; Scafetta, Roberta; Taurelli Salimbeni, Beatrice; Esposito, Angela; Zagami, Paola; Trapani, Dario; Malagutti, Bianca; Caputo, Roberta; Vernieri, Claudio; Munzone, Elisabetta; Scagnoli, Simone; Botticelli, Andrea; Lambertini, Matteo; Giuliano, Mario; De Laurentiis, Michelino; Viale, Giulia; Bianchini, Giampaolo; Curigliano, Giuseppe; De Angelis, Carmine
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

AKT和EZH2抑制剂通过劫持退化机制杀死TNBCs

Nature
IF48.5
2024-10-090
OAAI
Amy E. Schade; Naiara Perurena; Yoona Yang; Carrie L. Rodriguez; Anjana Krishnan; Alycia Gardner; Patrick Loi; Yilin Xu; Van T. M. Nguyen; G. M. Mastellone; Natalie F. Pilla; Marina Watanabe; Keiichi Ota; Rachel A. Davis; Kaia Mattioli; Dongxi Xiang; Jason J. Zoeller; Jia-Ren Lin; Stefania Morganti; Ana C. Garrido-Castro; Sara M. Tolaney; Zhe Li; David A. Barbie; Peter K. Sorger; Kristian Helin; Sandro Santagata; Simon R. V. Knott; Karen Cichowski
Quantitative standardized high sensitivity (HS)-HER2 testing predicts outcomes with trastuzumab deruxtecan (T-DXd) for metastatic breast cancer (MBC)

定量标准化的高灵敏度（HS）-HER2检测可预测曲妥珠单抗德鲁替康（T-DXd）对转移性乳腺癌（MBC）的疗效。

ANNALS OF ONCOLOGY
IF65.4
2024-09-012
PRE
Tarantino, P.; Kim, S. E.; Chan, N. N. N.; Hughes, M. E.; Smith, K.; D'Amico, O. R.; Kusmick, R.; Pereslete, A. M.; Alder, L.; Anders, C.; Morganti, S.; Garrido-Castro, A. C.; Lorusso, P.; Lustberg, M.; Sammons, S.; Lin, N.; Li, T.; Tayob, N.; Rimm, D.; Tolaney, S. M.
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials

年龄对早期临床试验中研究的新型癌症药物安全性和有效性的影响

EUROPEAN JOURNAL OF CANCER
IF7.1
2024-08-012
PRE
Nicolo, Eleonora; Gandini, Sara; Giugliano, Federica; Uliano, Jacopo; D'Ecclesiis, Oriana; Morganti, Stefania; Ferraro, Emanuela; Trapani, Dario; Tarantino, Paolo; Zagami, Paola; Boldrini, Laura; Caramella, Irene; Schianca, Ambra Carnevale; Cristofanilli, Massimo; Locatelli, Marzia Adelia; Esposito, Angela; Belli, Carmen; Minchella, Ida; Criscitiello, Carmen; Marra, Antonio; Curigliano, Giuseppe
Impact of HER2 expression dynamics on the realworld activity of trastuzumab deruxtecan for metastatic breast cancer (RELIEVE)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Tarantino, Paolo; Hughes, Melissa; Kusmick, Ross; Alder, Laura; Pereslete, Alyssa; Noteware, Laura; Moore, Heather; Van Swearingen, Amanda; Li, Tianyu; Gupta, Hersh; Smith, Kalie; Morganti, Stefania; Files, Janet; Sendrick, Kerry; Buck, Simone; Dillon, Deborah; Jeselsohn, Rinath; Li, Yvonne; Cherniack, Andrew; Prat, Aleix; Chan, Nay Nwe Nyein; Rimm, David; Curigliano, Giuseppe; Sammons, Sarah; Anders, Carey; Lin, Nancy; Tolaney, Sara
Are contralateral prophylactic mastectomy rates impacted by ASBrS guidelines to offer germline genetic testing to all patients with breast cancer? Results from a large, prospective, singleinstitution cohort
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Weiss, Anna; Knapp, Stephen; Braun, Danielle; Barton, Brenna; McGrath, Monica; Stokes, Samantha; Laws, Alison; Warren, Laura; Morganti, Stefania; Lynce, Filipa; Bychkovsky, Brittany; Rana, Huma; Davis, Dillon; Stopfer, Jill; Garber, Judy; King, Tari

研究方向

暂未获取到该数据
G
Giuseppe Curigliano
H 指数:118论文数:1,729被引数:7.4万
P
Paolo Tarantino
H 指数:34论文数:244被引数:5,783
A
Antonio Marra
H 指数:32论文数:242被引数:4,884
C
Carmen Criscitiello
H 指数:56论文数:368被引数:1.7万
S
Sara M. Tolaney
H 指数:83论文数:1,341被引数:3.6万
P
Paola Zagami
H 指数:18论文数:138被引数:1,893
N
Nancy U. Lin
H 指数:95论文数:1,074被引数:4.2万
F
Filipa Lynce
H 指数:29论文数:262被引数:4,986
T
Tari A. King
H 指数:73论文数:632被引数:3.6万
N
Nicola Fusco
H 指数:41论文数:397被引数:6,358